# OnCo record fnr-uruguay (institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/institutions/fnr-uruguay/>
  a schema:MedicalOrganization ;
  onco:kind "institution" ;
  schema:identifier "fnr-uruguay" ;
  schema:name "Fondo Nacional de Recursos (Uruguay)"@en ;
  schema:alternateName "FNR"@en, "FNR Uruguay"@en, "National Resource Fund of Uruguay"@en ;
  schema:description "Uruguay's national fund for high-cost care. It pays for specialised procedures and, since 2005, for high-cost medicines on the national formulary, including cancer medicines such as trastuzumab, pembrolizumab and osimertinib, for everyone covered by the national health system."@en ;
  schema:url <https://onco.cc/institutions/fnr-uruguay/>, <https://www.fnr.gub.uy> ;
  schema:dateModified "2026-11-11"^^xsd:date ;
  schema:citation <https://www.fnr.gub.uy/que-es-el-fondo-nacional-de-recursos/>, <https://www.fnr.gub.uy/historia/>, <https://www.fnr.gub.uy/tratamientos_medicamentos/>, <https://www.fnr.gub.uy/noticia_slide/octubre-rosa-2026/>, <https://www.fnr.gub.uy/wp-content/uploads/2024/11/memoria_2023.pdf>, <https://www.impo.com.uy/bases/leyes/16343-1992> ;
  schema:addressCountry "UY" ;
  schema:addressLocality "Montevideo" ;
  schema:latitude "-34.904"^^xsd:decimal ;
  schema:longitude "-56.188"^^xsd:decimal ;
  onco:related <https://onco.cc/technologies/global-oncology-access/> ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/lung-cancer/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/melanoma/> ;
  onco:drugs <https://onco.cc/drugs/trastuzumab/>, <https://onco.cc/drugs/pertuzumab/>, <https://onco.cc/drugs/fulvestrant/>, <https://onco.cc/drugs/ribociclib/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/osimertinib/>, <https://onco.cc/drugs/cetuximab/>, <https://onco.cc/drugs/daratumumab/>, <https://onco.cc/drugs/imatinib/>, <https://onco.cc/drugs/rituximab/> ;
  onco:institutions <https://onco.cc/institutions/msp-uruguay/> .
